Mubalake Abudoureyimu
Overview
Explore the profile of Mubalake Abudoureyimu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
146
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lai Y, Feng B, Abudoureyimu M, Zhi Y, Zhou H, Wang T, et al.
Front Oncol
. 2019 Nov;
9:1156.
PMID: 31750247
As the first oral multi-target anti-tumor drug proved for the treatment of patients with advanced liver cancer in 2007, sorafenib has changed the landscape of advanced hepatocellular carcinoma (HCC) treatment....
12.
Zhi Y, Abudoureyimu M, Zhou H, Wang T, Feng B, Wang R, et al.
Mol Ther Nucleic Acids
. 2019 May;
16:576-588.
PMID: 31082791
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-associated death worldwide. Indeed, despite the benefit of sorafenib in the treatment of some patients with HCC, the majority of these...
13.
Abudoureyimu M, Zhou H, Zhi Y, Wang T, Feng B, Wang R, et al.
Cell Prolif
. 2018 Nov;
52(2):e12541.
PMID: 30397975
Exosomes are small membrane vesicles 50-150 nm in diameter released by a variety of cells, which contain miRNAs, mRNAs and proteins with the potential to regulate signalling pathways in recipient...